Losartan Potassium
Product Images NDC 13107-196

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 13107-196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line chart comparing the percentage of patients with the primary endpoint over a study period of up to 66 months between Atenolol and Losartan Potassium. The chart shows adjusted risk reduction with a statistical significance noted.*

FDA Label Image

Figure2 (Figure2)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over time between Atenolol and Losartan Potassium groups. The x-axis shows study months from 0 to 66, and the y-axis shows the percentage of patients. The graph includes a note of an adjusted risk reduction of 25% with a p-value of 0.001.*

FDA Label Image

Figure3 (Figure3)

A forest plot chart titled 'Primary Endpoint Events within Demographic Subgroups' comparing event rates for Losartan Potassium and Atenolol across various subgroups. It shows hazard ratios with 95% confidence intervals for Primary Composite events and Stroke (Fatal/Non-fatal), plotting whether data favors Losartan Potassium or Atenolol. Subgroups include age, gender, race, ischemic heart disease, diabetes, and history of cardiovascular disease.*

FDA Label Image

Figure4 (Figure4)

A line graph depicting the percentage of patients with an event over 48 months for Losartan Potassium compared to a placebo. The graph shows risk reduction of 16.1% with a p-value of 0.022, featuring a solid line for Losartan Potassium and a dashed line for placebo.*

FDA Label Image

Losartanpotasium100mg90ct.jpg (Losartanpotasium100mg90ct)

Label for Losartan Potassium Tablets USP 100 mg by Aurolife Pharma LLC. The label states the active ingredient is losartan potassium USP 100 mg per film-coated tablet and the package contains 90 tablets. It includes storage instructions and mentions the product is prescription only.*

FDA Label Image

Losartanpotasium25mg90ct.jpg (Losartanpotasium25mg90ct)

Losartan Potassium Tablets USP 25 mg film-coated tablets, packaged in a bottle of 90 tablets. Label shows NDC 13107-195-90 and is distributed by Aurolife Pharma LLC, Dayton, NJ. Label includes storage instructions and dosage reference to package insert.*

FDA Label Image

Losartanpotasium50mg90ct.jpg (Losartanpotasium50mg90ct)

Losartan Potassium Tablets USP 50 mg film-coated tablets label, containing 90 tablets. Distributed by Aurolife Pharma LLC, Dayton, NJ. The label includes dosage strength, storage instructions, and regulatory information such as NDC 13107-196-90 and prescription status (Rx only).*

FDA Label Image

Structure (Structure)

Chemical structure of losartan potassium, showing the molecule's atomic connections including chlorine, nitrogen atoms in rings, and a potassium ion depicted externally on the side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.